Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element
Timothy A. Vickers(Ionis Pharmaceuticals (United States)), David J. Ecker(University of Colorado Denver), Brenda F. Baker(Ionis Pharmaceuticals (United States)), J Germany(Southern Research Institute), Maryann C. Zounes(Ionis Pharmaceuticals (United States)), Robert W. Buckheit(Ionis Pharmaceuticals (United States)), P. Dan Cook(Ionis Pharmaceuticals (United States))
Cited by 133
Related Papers
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Evaluation of 2‘-modified oligonucleotides containing 2‘-deoxy gaps as antisense inhibitors of gene expression
|Journal of Biological Chemistry|1993|770
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
|New England Journal of Medicine|2015|526
Targeting APOC3 in the Familial Chylomicronemia Syndrome
|New England Journal of Medicine|2014|492